Autoimmune rippling muscle

Neurology

Volumn 61, Issue 6, 2003, Pages 869-870

  Muley, Suraj Ashok ^a,b   Day, John W ^a  

^a Department of Neurology ^*  (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; ELECTROMYOGRAM; HUMAN; MALE; MOTOR ACTIVITY; MUSCLE CONTRACTURE; MUSCLE STIFFNESS; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; RIPPLING MUSCLE DISEASE;

EID: 0141764901     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000068529.36993.03     Document Type: Article

References (5)

1. Ricker K, Moxley RT, Rohkamm R. Rippling muscle disease. Arch Neurol 1989;46:405-408.
2. Stephan DA, Buist NRM, Chittenden AB, Ricker K, Zhou J, Hoffman EP. A rippling muscle disease gene is localized to 1q41. Neurology 1994;44:1915-1920.
3. Betz RC, Schoser BGH, Kasper D, et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001;28:218-219.
4. Muller-Felber W, Ansevin CF, Ricker K, et al. Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis. Neuromuscul Disord 1999;9:604-607.
5. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 2002;26:702-707.